查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1701356

體外大腸直腸癌篩檢測試市場規模、佔有率和趨勢分析報告：按測試、最終用途、地區、

In-vitro Colorectal Cancer Screening Tests Market Size, Share & Trends Analysis Report By Test (Fecal Occult Blood Tests, Biomarker Tests), By End-use (Hospitals & Clinics, Diagnostic Laboratories),By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 129 Pages | 商品交期: 2-10個工作天內

價格

體外大腸直腸癌篩檢測試市場成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球體外大腸癌篩檢市場規模預計到2030年將達到17億美元，2025年至2030年的複合年成長率為4.7%。

為了應對日益增多的結腸和直腸惡性腫瘤患者，新的篩檢模型的出現是影響市場成長的主要因素。腫瘤M2-PK糞便檢驗和甲基化基因檢測等新開發的基因和生物標記檢測的出現有望提高腫瘤診斷模型的採用率。

大腸直腸惡性腫瘤發生率的不斷上升是該領域成長的主要驅動力。例如，根據日本國家癌症中心2022年6月發布的數據，預計2022年日本將新增約101.9萬例癌症病例，其中結直腸癌（CRC）預計將佔15.82萬例新病例。同樣，根據澳洲癌症協會 2022 年 8 月更新的數據，預計 2022 年澳洲將診斷出 15,713 例新的 CRC 病例，其中男性診斷出 8,300 例，女性診斷出 7,413 例。因此，預計大腸直腸惡性腫瘤盛行率的上升將推動對大腸鏡檢查設備的需求。

政府當局為促進篩檢而實施的各種舉措正在對體外 CRC 篩檢的需求產生積極影響。例如，Cancer.org 報告稱，加州衛生系統在 2020 年 4 月至 5 月期間繼續提供 FIT套件（糞便免疫化學檢查），儘管爆發了 COVID-19 疫情，但 FIT 的回應率仍然很高。此外，歐洲癌症界已調動資源來評估、解決和減輕COVID-19對篩檢的負面影響。這些努力有助於維持對體外篩檢測試的需求。

此外，預計市場成長將受到主要市場參與企業增加產品推出的推動。這些產品的發布旨在提供技術先進和創新的產品。例如，Pillar Biosciences, Inc. 於 2021 年 7 月獲得 FDA核准使用 ONCO/Reveal Dx 肺癌和結腸癌檢測 (O/RDx-LCCA) 來檢測 CRC。

體外大腸直腸癌篩檢測試市場亮點：

  • 大便潛血試驗部分將主導體外大腸直腸癌篩檢檢測產業，2024 年的最大收益佔有率將達到 82.3%。生物標記測試領域預計將成為成長最快的領域，2025 年至 2030 年的複合年成長率為 5.8%。
  • 診斷實驗室部門憑藉其先進的技術、高精度和全面的測試能力，預計將在 2024 年佔據最大的收益佔有率。由於對早期診斷和非侵入性檢測選項的需求不斷成長，醫院和診所部門預計在預測期內將以顯著的速度成長。
  • 2024 年，北美體外大腸直腸癌篩檢測試市場佔據全球市場主導地位，收益佔有率最大，為 39.5%。 2024 年，美國體外大腸直腸癌篩檢測試市場佔有最大佔有率。
  • 2025 年至 2030 年期間，亞太地區體外結直腸癌篩檢測試市場將以 5.2% 的最快複合年成長率擴張。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 體外大腸直腸癌篩檢測試市場變數、趨勢和範圍

  • 市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析-波特五力分析
    • PESTLE分析

第4章體外大腸直腸癌篩檢測試市場：測試業務分析

  • 2024年和2030年的測試市場佔有率
  • 檢查細分儀表板
  • 市場規模、預測與趨勢分析（按測試，2018-2030 年）
  • 大便潛血試驗
  • 生物標記檢測
  • 其他方法

5. 體外大腸直腸癌篩檢測試市場：依最終用途分類的業務分析

  • 2024 年及 2030 年最終用途市場佔有率
  • 最終用途細分儀表板
  • 2018 年至 2030 年市場規模、預測、趨勢分析（按應用）
  • 醫院和診所
  • 診斷實驗室
  • 其他

6. 體外大腸直腸癌篩檢市場：區域估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 市場規模、預測趨勢分析，2018 年至 2030 年：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/列表
    • Abbott
    • Epigenomics AG
    • Beckman Coulter, Inc.
    • Eiken Chemical Co., Ltd.
    • Sysmex Corporation
    • Siemens Healthineers AG
    • Quest Diagnostics Incorporated
    • Oncocyte Corporation
    • Merck KGaA
    • Immunostics Inc.
    • Kyowa Kirin Co., Ltd.
    • Randox Laboratories Ltd.
    • R-Biopharm AG
Product Code: 978-1-68038-438-3

In-vitro Colorectal Cancer Screening Tests Market Growth & Trends:

The global in-vitro colorectal cancer screening tests market size is expected to reach USD 1.7 billion by 2030, registering a CAGR of 4.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising number of novel screening models to combat the increasing incidences of colon and rectal malignancy cases is the major factor influencing the market growth. The emergence of newly developed genetic and biomarker tests such as tumor M2-PK stool tests and methylated gene testing is anticipated to drive the adoption rate of tumor diagnostic models.

The increasing incidence of colorectal malignancy is a significant driver for the growth of the segment. For example, according to data released by the National Cancer Center Japan in June 2022, it was projected that there would be approximately 1,019,000 new cases of cancer in Japan in 2022, with Colorectal Cancer (CRC) accounting for an estimated 158,200 new cases. Similarly, data updated by Cancer Australia in August 2022 indicated that 15,713 new cases of CRC were expected to be diagnosed in Australia in 2022, with 8,300 cases among males and 7,413 cases among females. As a result, the increasing prevalence of colorectal malignance is anticipated to drive the demand for colonoscopy devices.

The implementation of various initiatives by public organizations to promote screening has positively impacted the demand for in-vitro CRC screenings. For instance, according to reports from Cancer.org, healthcare systems in California continued to provide FIT kits (fecal immunochemical tests) during the months of April and May 2020, and the response rates for FIT remained high despite the onset of the COVID-19 pandemic. Additionally, the European Cancer community has mobilized its resources to evaluate, address, and mitigate the adverse effects of COVID-19 on screening. These efforts have contributed to the sustained demand for in-vitro screening tests.

Furthermore, market growth is expected to be driven by the increasing number of product launches by major market players. These product launches are aimed at providing access to technologically advanced and innovative products. For instance, Pillar Biosciences, Inc. received FDA approval for the ONCO/Reveal Dx Lung & Colon Cancer Assay (O/RDx-LCCA) in July 2021 for the detection of CRC.

In-vitro Colorectal Cancer Screening Tests Market Report Highlights:

  • The fecal occult blood tests segment dominated the in-vitro colorectal cancer screening tests industry, with the largest revenue share of 82.3% in 2024. The biomarker tests segment is anticipated to emerge as the fastest-growing segment and grow at a CAGR of 5.8% from 2025 to 2030.
  • The diagnostic laboratories segment held the largest revenue share in 2024, attributed to their advanced technology, high accuracy, and comprehensive testing capabilities. The hospitals and clinics segment is expected to grow at a significant pace during the forecast period, fueled by the increasing demand for early diagnosis and noninvasive testing options.
  • North America in-vitro colorectal cancer screening tests market dominated the global market with the largest revenue share of 39.5% in 2024. The U.S. in-vitro colorectal cancer screening tests market held the largest share in 2024.
  • Asia Pacific in-vitro colorectal cancer screening tests market is set to expand at the fastest CAGR of 5.2% from 2025 to 2030.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Test
    • 1.2.2. End Use
    • 1.2.3. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. In-vitro Colorectal Cancer Screening Tests Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. In-vitro Colorectal Cancer Screening Tests Market: Test Business Analysis

  • 4.1. Test Market Share, 2024 & 2030
  • 4.2. Test Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, By Test, 2018 to 2030 (USD Million)
  • 4.4. Fecal Occult Blood Tests
    • 4.4.1. Fecal Occult Blood Tests Market, 2018 - 2030 (USD Million)
    • 4.4.2. Guaiac FOB Stool Test
      • 4.4.2.1. Guaiac FOB Stool Test Market, 2018 - 2030 (USD Million)
    • 4.4.3. Immuno-FOB Agglutination Test
      • 4.4.3.1. Immuno-FOB Agglutination Test Market, 2018 - 2030 (USD Million)
    • 4.4.4. Lateral Flow Immuno-FOB Test
      • 4.4.4.1. Lateral Flow Immuno-FOB Test Market, 2018 - 2030 (USD Million)
    • 4.4.5. Immuno-FOB ELISA Test
      • 4.4.5.1. Immuno-FOB ELISA Test Market, 2018 - 2030 (USD Million)
  • 4.5. Biomarker Tests
    • 4.5.1. Biomarker Tests Market, 2018 - 2030 (USD Million)
  • 4.6. Other Methods
    • 4.6.1. Other Methods Market, 2018 - 2030 (USD Million)

Chapter 5. In-vitro Colorectal Cancer Screening Tests Market: End Use Business Analysis

  • 5.1. End Use Market Share, 2024 & 2030
  • 5.2. End Use Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, By End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals and Clinics
    • 5.4.1. Hospitals and Clinics Market, 2018 - 2030 (USD Million)
  • 5.5. Diagnostic Laboratories
    • 5.5.1. Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. In-vitro Colorectal Cancer Screening Tests Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamic
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamic
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamic
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. U.K.
      • 6.5.2.1. Key Country Dynamic
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. U.K. In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamic
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. Spain
      • 6.5.4.1. Key Country Dynamic
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. Spain In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. France
      • 6.5.5.1. Key Country Dynamic
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. France In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Italy
      • 6.5.6.1. Key Country Dynamic
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Italy In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamic
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Denmark In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamic
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Sweden In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamic
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Norway In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamic
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamic
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamic
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamic
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamic
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamic
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamic
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamic
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Middle East and Africa In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamic
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamic
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamic
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamic
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Abbott
      • 7.5.1.1. Participant's Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Epigenomics AG
      • 7.5.2.1. Participant's Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Beckman Coulter, Inc.
      • 7.5.3.1. Participant's Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Eiken Chemical Co., Ltd.
      • 7.5.4.1. Participant's overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Sysmex Corporation
      • 7.5.5.1. Participant's Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Siemens Healthineers AG
      • 7.5.6.1. Participant's Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Quest Diagnostics Incorporated
      • 7.5.7.1. Participant's Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Oncocyte Corporation
      • 7.5.8.1. Participant's Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Merck KGaA
      • 7.5.9.1. Participant's Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Immunostics Inc.
      • 7.5.10.1. Participant's Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives
    • 7.5.11. Kyowa Kirin Co., Ltd.
      • 7.5.11.1. Participant's Overview
      • 7.5.11.2. Financial Performance
      • 7.5.11.3. Product Benchmarking
      • 7.5.11.4. Strategic Initiatives
    • 7.5.12. Randox Laboratories Ltd.
      • 7.5.12.1. Participant's Overview
      • 7.5.12.2. Financial Performance
      • 7.5.12.3. Product Benchmarking
      • 7.5.12.4. Strategic Initiatives
    • 7.5.13. R-Biopharm AG
      • 7.5.13.1. Participant's Overview
      • 7.5.13.2. Financial Performance
      • 7.5.13.3. Product Benchmarking
      • 7.5.13.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global In-vitro Colorectal Cancer Screening Tests Market, By Region, 2018 - 2030 (USD Million)
  • Table 4. Global In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 5. Global In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 6. North America In-vitro Colorectal Cancer Screening Tests Market, By Country, 2018 - 2030 (USD Million)
  • Table 7. North America In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 8. North America In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 9. U.S. In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 10. U.S. In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 11. Canada In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 12. Canada In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 13. Mexico In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 14. Mexico In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 15. Europe In-vitro Colorectal Cancer Screening Tests Market, By Country, 2018 - 2030 (USD Million)
  • Table 16. Europe In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 17. Europe In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 18. U.K. In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 19. U.K. In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 20. Germany In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 21. Germany In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 22. Spain In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 23. Spain In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 24. France In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 25. France In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26. Italy In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 27. Italy In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28. Denmark In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 29. Denmark In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 30. Sweden In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 31. Sweden In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32. Norway In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 33. Norway In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific In-vitro Colorectal Cancer Screening Tests Market, By Country, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37. Japan In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 38. Japan In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 39. China In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 40. China In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41. India In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 42. India In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 43. South Korea In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 44. South Korea In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 45. Australia In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 46. Australia In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 47. Thailand In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 48. Thailand In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 49. Latin America In-vitro Colorectal Cancer Screening Tests Market, By Country, 2018 - 2030 (USD Million)
  • Table 50. Latin America In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 51. Latin America In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52. Brazil In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 53. Brazil In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 54. Argentina In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 55. Argentina In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market, By Country, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 58. Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 59. South Africa In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 60. South Africa In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 63. UAE In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 64. UAE In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65. Kuwait In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 66. Kuwait In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 In-vitro Colorectal Cancer Screening Tests Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Test and End Use Outlook (USD Million)
  • Fig. 11 Competitive Landscape
  • Fig. 12 In-vitro Colorectal Cancer Screening Tests Market Dynamics
  • Fig. 13 In-vitro Colorectal Cancer Screening Tests Market: Porter's Five Forces analysis
  • Fig. 14 In-vitro Colorectal Cancer Screening Tests Market: PESTLE Analysis
  • Fig. 15 In-vitro Colorectal Cancer Screening Tests Market: Test Segment Dashboard
  • Fig. 16 In-vitro Colorectal Cancer Screening Tests Market: Test Market Share Analysis, 2024 & 2030
  • Fig. 17 Fecal Occult Blood Tests Market, 2018 - 2030 (USD Million)
  • Fig. 18 Biomarker Tests Market, 2018 - 2030 (USD Million)
  • Fig. 19 Other Methods Market, 2018 - 2030 (USD Million)
  • Fig. 20 In-vitro Colorectal Cancer Screening Tests Market: End Use Segment Dashboard
  • Fig. 21 In-vitro Colorectal Cancer Screening Tests Market: End Use Market Share Analysis, 2024 & 2030
  • Fig. 22 Hospitals and Clinics Market, 2018 - 2030 (USD Million)
  • Fig. 23 Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
  • Fig. 24 Others Market, 2018 - 2030 (USD Million)
  • Fig. 25 In-vitro Colorectal Cancer Screening Tests Market Revenue, By Region
  • Fig. 26 Regional Marketplace: Key Takeaways
  • Fig. 27 Regional Marketplace: Key Takeaways
  • Fig. 28 North America In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Country Dynamics
  • Fig. 30 U.S. In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 31 Canada Country Dynamics
  • Fig. 32 Canada In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico Country Dynamics
  • Fig. 34 Mexico In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 35 Europe In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 36 U.K. Country Dynamics
  • Fig. 37 U.K. In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany Country Dynamics
  • Fig. 39 Germany In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 40 Spain Country Dynamics
  • Fig. 41 Spain In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 42 France Country Dynamics
  • Fig. 43 France In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy Country Dynamics
  • Fig. 45 Italy In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark Country Dynamics
  • Fig. 47 Denmark In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden Country Dynamics
  • Fig. 49 Sweden In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 50 Norway Country Dynamics
  • Fig. 51 Norway In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan Country Dynamics
  • Fig. 54 Japan In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 55 China Country Dynamics
  • Fig. 56 China In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 57 India Country Dynamics
  • Fig. 58 India In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 59 South Korea Country Dynamics
  • Fig. 60 South Korea In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 61 Australia Country Dynamics
  • Fig. 62 Australia In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand Country Dynamics
  • Fig. 64 Thailand In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil Country Dynamics
  • Fig. 67 Brazil In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina Country Dynamics
  • Fig. 69 Argentina In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 70 Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa Country Dynamics
  • Fig. 72 South Africa In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 73 Saudi Arabia Country Dynamics
  • Fig. 74 Saudi Arabia In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 75 UAE Country Dynamics
  • Fig. 76 UAE In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 77 Kuwait Key Country Dynamics
  • Fig. 78 Kuwait In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 79 Company Categorization
  • Fig. 80 Company Market Position Analysis
  • Fig. 81 Strategic Framework